SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-023663
Filing Date
2024-02-14
Accepted
2024-02-14 16:15:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm246100d1_sc13ga.htm SC 13G/A 38732
  Complete submission text file 0001104659-24-023663.txt   39932
Mailing Address
Business Address
LEVIN JEREMY M (Filed by) CIK: 0001256153 (see all company filings)

Type: SC 13G/A

Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90350 | Film No.: 24638405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)